LINDA PEREZ: Open Payments
NPI 1568074177 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 226 payments from 13 companies in 2025. Trend: 2023 $964 · 2024 $1,999 · 2025 $2,701
Food & beverage: $2,701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $399 |
| E.R. Squibb & Sons, L.L.C. | 21 | $396 |
| Neurocrine BioSciences, Inc. | 27 | $320 |
| Corium, LLC | 16 | $306 |
| Otsuka America Pharmaceutical, Inc. | 34 | $274 |
| Lundbeck LLC | 38 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $210 |
| Alkermes, Inc. | 21 | $173 |
| Axsome Therapeutics, Inc. | 5 | $129 |
| Janssen Pharmaceuticals, Inc | 5 | $102 |
Products named: REXULTI, VRAYLAR, COBENFY, INGREZZA, Azstarys, CAPLYTA, ARISTADA, Auvelity.
Industry payments across TX — which companies pay providers there.
